Skip to main navigation

Skip to content

Customer Service: 866-788-9007

PHYSICIAN LOGIN | CRF LOGIN

ORDER TEST

Company
Products
Research & Development
Investors
Scientific Publications
Resources

December 3, 2019 Castle Biosciences Announces Time Change for Presentation at the Evercore ISI Second Annual HealthCONx

Events & Presentations

Events & Presentations

Castle Biosciences Q3 2019 Earnings Call

Nov 11, 2019 at 4:30 PM EST

Listen to webcast

Latest News

Castle Biosciences Announces Time Change for Presentation at the Evercore ISI Second Annual HealthCONx December 3, 2019
Castle Biosciences Presents Expanded Data Supporting Use of DecisionDx-Melanoma Test to Inform Sentinel Lymph Node Biopsy Recommendations November 25, 2019
Castle Biosciences to Present at Upcoming Investor Conferences November 20, 2019
Castle Biosciences Reports Third Quarter 2019 Results November 11, 2019
Study Results Confirm Newly Developed Nomogram Using Castle Biosciences’ DecisionDx-Melanoma Test Improves Assessment of Melanoma Patient Risk October 31, 2019

Site - Investor Tools

Print Page

RSS Feeds

Email Alerts

Investor Contact

Investor Contact

Search

Connect with Us

Company

About Us
History
Leadership
- Executive Management
- Board of Directors
Licenses
Careers
Contact Us

Products

Cutaneous Melanoma
- DecisionDx-Melanoma
- DecisionDx-CMSeq
Uveal Melanoma

Research & Development

Our Approach
Tests in Development
Cutaneous Squamous Cell Carcinoma
Suspicious Pigmented Lesions

Latest News & Publications

Press Releases
Scientific Publications
Email Alerts

Resources

Healthcare Professionals
Patients

Copyright © 2019 Castle Biosciences, Inc. | All Rights Reserved

Privacy Policy
Terms of Use
Contact Us

7ads6x98y